Loading
Latest filing published 03 Aug 2022 for TuHURA Biosciences, Inc./NV.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Anthony Scott Praill on record concern TuHURA Biosciences, Inc./NV, in the capacity of finance chief. The record holds 9 filings, for trades running from 29 March 2019 to 1 August 2022.
On the market, this insider has only ever bought: 1 purchase, €17k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
Most recently, on 3 August 2022, the filings show a share grant in TuHURA Biosciences, Inc./NV. The clock since the last published purchase (9 December 2021) now reads 1,780 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations